Boehringer Ingelheim wins Best in Pharma

Boehringer Ingelheim has received the Best in Pharma award for the second year as part of In Business magazines editors choice awards.
The award was given in recognition of Boehringer Ingelheim’s continued work with social and health entrepreneurs. This work consisted of social projects aimed at solving some of Ireland’s greatest challenges, through the transfer of skills, knowledge and expertise.
In Business said the award was given in recognition of the company’s corporate culture of taking social responsibility coupled with the ongoing commitment to research and innovation in the pharmaceutical industry, while helping the medical profession deliver expert healthcare to patients.
The In Business editorial team considered a number of factors when choosing the winner including: research and development, profile of the business, commitment to Ireland, with particular emphasis on the contribution made to the healthcare sector as a result of additional initiatives.
The team considered the number and quality of initiatives made by each company, relative to the size of the company, as well as how effective each company was in communicating their initiatives to key stakeholders in the healthcare sector.
Boehringer Ingelheim was selected from 28 pharmaceutical companies in Ireland and community and the editorial team felt that it had demonstrated a very high standard of excellence in terms of the number and potential impact of initiatives it sponsored as well as the proactive way it communicated with the wider healthcare business and consumer communities.
A spokesperson for Boehringer Ingelheim said: “Taking social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative Making more Health and caring for the employees. Respect, equal opportunities and reconciling career and family form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability.”
According to the company, its focus is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. Visit www.boehringer-ingelheim.com